A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

키워드

참고문헌 (16)

1. Maurice J, "Non-alcoholic fatty liver disease", Clin Med(Lond), 18, pp.245~250 (2018)
2. Friedman SL, "Mechanisms of NAFLD development and therapeutic strategies", Nat Med, 24, pp.908~922 (2018)
3. Rotman Y, "Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease", Gut, 66, pp.180~190 (2017)
4. Bril F, "Response to pioglitazone in patients with nonalcoholic steatohepatitis with vs without type 2 diabetes", Clin Gastroenterol Hepatol, 16, pp.558~566 (2018)
5. Gallwitz B, "Clinical use of DPP-4 inhibitors", Front Endocrinol(Lausanne), 10, pp.389~ (2019)
6. Barchetta I, "Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD", NASH in individuals with and without obesity and metabolic disease, 2021, pp.44, 979~988
7. Alam S, "Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients : a 1-year randomized control trial", Hepat Med, 10, pp.23~31 (2018)
8. 김미경, "Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models", Archives of Pharmacal Research, 40(2), pp.268~281 (2017), 대한약학회
9. Nakamura K, "A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob", ob mice, 2017, pp.39, 969~983
10. 오주희, "Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial", Clinical and Molecular Hepatology, 28(3), pp.497~509 (2022), 대한간학회[DOI]
11. Lewitt MS, "Insulin-like growth factor-binding protein-1 modulates blood glucose levels", Endocrinology, 129, pp.2254~2256 (1991)
12. Yki-Järvinen H, "Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo", J Clin Endocrinol Metab, 80, pp.3227~3232 (1995)
13. Stanley TL, "Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease", J Clin Endocrinol Metab, 106, pp.e520~e533 (2021)
14. Lewitt MS, "Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men", Diabetologia, 51, pp.1135~1145 (2008)
15. Farrell G, "Mouse models of nonalcoholic steatohepatitis : toward optimization of their relevance to human nonalcoholic steatohepatitis", Hepatology, 69, pp.2241~2257 (2019)
16. Deacon CF, "A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials", Diabetes Obes Metab, 20(1), pp.34~46 (2018)

관련 논문AI추천